奶牛复合酶制剂FE907对泌乳早期奶牛生产性能和经济效益的影响

目的:研究酶制剂对泌乳奶牛生产性能和疾病的影响.方法:选取28头泌乳荷斯坦奶牛,随机分为2组,每组14头.2组奶牛在全混合日粮上分别添加0、20 g/(头·d)复合酶制剂FE907,实验期4周.结果:实验组奶牛日均产乳量提高了1.6 kg/d(P＞0.05);实验组乳脂率比对照组提高0.08％,乳脂量提高0.09 kg/d,差异显著(P＜0.05),乳蛋白率提高0.06％,乳蛋白量提高0.07 kg/d,经济效益每天每头奶牛比对照组多盈利6.28元.结论:奶牛日粮中添加20 g/(头·d)的奶牛复合酶制剂FE907,可以提高产乳量,改善乳成分,提高经济效益,同时,可以在一定程度上降低患乳房炎的风险.     

Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts

Nine dairy herds (mean size, 149 cows) with bulk-tank milk somatic cell counts of less than 300,000 cells/ml and greater than 80% of cows with Dairy Herd Improvement Association linear somatic cell counts less than or equal to 4 were selected for study. Each herd was monitored for 12 consecutive months. Duplicate quarter-milk specimens were collected from each cow for bacteriologic culturing at beginning of lactation, cessation of lactation, and at the time of each clinical episode of mastitis. Streptococcus agalactiae was never isolated and Staphylococcus aureus was isolated from less than 1% of all quarters. There were 554 episodes of clinical mastitis. During the year of study, the incidence rate of clinical mastitis varied from 15.6 to 63.7% of cows among the 9 herds. Mean costs per cow per year in herd for mastitis prevention were: $10 for paper towels, $3 for nonlactating cow treatment, and $10 for teat disinfectants. Mean cost associated with clinical mastitis was $107/episode. Approximately 84% ($90) of the costs attributed to a clinical episode were associated with decreased milk production and nonsalable milk. Costs of medication and professional veterinary fees per clinical episode varied significantly among the 9 herds. Three of the herds did not have a veterinarian treat a clinical episode of mastitis during the year of study even though 2 of these herds had the first and third highest incidence rates of clinical mastitis. When calculated on a per cow in herd basis, mean costs of $40/cow/year were attributed to clinical mastitis.(ABSTRACT TRUNCATED AT 250 WORDS)     

A large scale mastitis control programme in Somerset.

The results of a mastitis control programme operated in south west England for three years are given. Farmers participating in the full mastitis control group agreed to treat each cow at drying off with 500 mg benzathine cloxacillin in each quarter, to have their milking machines tested and to correct any faults, and to practise teat dipping. Data covering cell counts, milk production, milk quality and clinical mastitis, were assessed from herds taking part in the programme. Cell counts were analysed from all 507 herds taking part in the programme. Milk production records for the full mastitis control group (188 herds) over a three year period are discussed, and these results compared with milk production figures from Milk Marketing Board records from herds in the south west of England which were carrying out no specific mastitis control programme. The milk quality data compare the findings in 159 herds in the full mastitis control programme with those in 247 herds in the partial and no mastitis control groups. Cases of clinical mastitis during the three year period were recorded in 73 herds in the full mastitis control group. The problems of applying the control routines are presented with observations on clinical mastitis, bulk milk cell count, milk production and milk quality. After three years, herds in the programme had on average increased milk production by 75 gallons a cow, achieved a 14.6 per cent reduction in the incidence of clinical mastitis, and improved the milk total solids percentage by one milk quality payment class.     

规模化奶牛场乳腺炎预防研究

[目的]为了降低规模化奶牛场乳腺炎发病率,提高奶牛生产性能。[方法]在干奶期对规模化奶牛场奶牛日粮添加盐酸左旋咪唑7．5mg／kg体重和亚硒酸钠维生素E10g／次·头的不同处理方法预防下一胎次乳腺炎的研究。[结果]表明：盐酸左旋咪唑组、亚硒酸钠维生素E组、盐酸左旋咪唑和亚硒酸钠维生素E组与对照组相比,下一胎次产犊后90d内的平均产奶量分别高1．3kg、1．5kg和2．5kg（P〈0．01）;盐酸左旋咪唑组、亚硒酸钠维生素E组间差异不显著,但两者同时使用具有加性效应,可进一步显著提高产奶量（P〈0．05）;下一胎次产犊后15～90d平均隐性乳腺炎阳性率减少6．6、9．2、15．9个百分点,差异极显著（P〈0．01）,盐酸左旋咪唑组、亚硒酸钠维生素E组隐性乳腺炎阳性率差异不显著（P〉0．05）,但与盐酸左旋咪唑加亚硒酸钠维生素E组间有显著差异（P〈0．05）;下一胎次产犊后90d内牛奶中体细胞数（SCC）平均分别减少7．4万／mL、9万／mL和13．2万／mL,分别降低了13．8％、16．8％、和24．7％,各组间差异极显著（P〈0．01）。[结论]说明盐酸左旋咪唑和亚硒酸钠在干奶期添加具有良好的降低乳房炎和提高产奶量的作用。     

The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows

The economic benefits of treating lactating cows for Streptococcus agalactiae mastitis were studied at a large (689 milking cows) central California dairy. Postcure milk production of case cows (infected, treated, and cured) was compared with production of paired control cows (uninfected) and was matched for yield, days in milk, days in gestation, and parity. A simulation was used to plot expected lactation curves for mastitic cows (infected, not treated) with characteristics similar to those of each control cow, and these curves were compared with actual case-cow lactation curves. The difference in actual and expected production was used to calculate net economic benefits of treatment. Comparison of expected with actual production indicated a net benefit from treatment of $396/cow for cows treated in early lactation and $237 for cows treated in midlactation, but a net loss of $55 for cows treated in late lactation. Lactation number did not have a significant impact on economic benefits of treatment. In contrast to other studies indicating no economic benefit from treating mastitis during lactation, this study's positive results may have been attributable to the high cure rate (98%) and the subclinical form of mastitis being treated. Streptococcus agalactiae mastitis treatment during early and midlactation would appear to be an economically justifiable option for dairy managers.     

张家口市塞北管理区种草养畜的成本收益分析

为给华北农牧交错带典型区域张家口市塞北管理区的农、牧业结构调整提供决策支持,在实地调研基础上,对当地种草养畜进行成本收益分析.结果表明:饲草、饲料作物的成本纯收益率为45.2%~125.1%,依次是青贮玉米>青稞>禾本科牧草≥豆科牧草;青贮玉米和多年生牧草的生产成本分别为其购入价格的44.4%~59.1%和48.6%~68.9%;投入不足是限制青贮玉米生产效益提高的主要因子;"全年舍饲"模式下,产奶量4550~6300 kg/头的中、高产奶牛的养殖纯收益为-86.5~1544.2元/头,成本纯收益率为-1.1%~15.5%,盈亏临界产奶量为4588.1~4789.8 kg/头;"舍饲+暖季放牧"模式下,种草养畜(中、高产奶牛)的纯收益为1453.6~3435.2元/头,51.0%以上的纯收益来源于饲草种植,成本纯收益率为22.7%~42.5%,盈亏临界产奶量为2850.0~3182.8 kg/头.     

饮水中添加湿态发酵蛋白饲料提高奶牛产奶量试验

湿态发酵蛋白饲料是玉米经酵母发酵、提取酒精后,又经益生菌发酵、密封包装的产物,其可溶性好、易消化、易吸收、蛋白质含量高。通过对奶牛进行饲喂试验可知,奶牛日添加4kg该饲料,单产可提高2.18kg,每头牛日增利润2.03元,增产效果好,经济效益显著;另外,研究还发现,日添加4kg该饲料对乳成分无显著影响。     

Milk production increase following treatment of Dutch dairy cattle with thiabendazole

Summary In a trial involving 542 dairy cattle on 28 farms, 276 were treated once with thiabendazole within two days of calving. The treated group showed an average increase in milk yielded over the non-return group of 229.8 kg during the subsequent lactation. In the treated group, total milk fat production was increased over that of the controls by 7.4 kg per cow; milk protein was increased by 6.9 kg per cow. All treatment parameter differences were highly significant at the 1% level of probability.     

VMP降低奶牛胎衣不下发病率试验

西安市第二奶牛场以改善综合营养供应为措施 ,即增加维生素、微量元素和蛋白质供应 ,胎衣不下的发病率从 1992 - 1998年的2 6 .2 % (497/ 1895 )降低到 1999- 2 0 0 1年的16 .4 % (15 4/ 94 1) ,成乳牛年均产奶量从 70 0 0kg提高到 75 0 0～ 80 0 0 kg。     

"溶菌酶"治疗奶牛隐性乳腺炎降低体细胞数临床应用和研究

选择上海金山新农奶牛场泌乳期SMT检查阳性（＋）以上，体细胞数50YY／mL以上的牛55头，通过溶菌酶临床治疗15天，隐性乳腺炎治愈率为65．86％，有效率为97．56％，细菌总数平均下降13．85万／mL．体细胞数平均下降54．1万／mL，日产量平均增加1．96kg。     

贝尔美对奶牛泌乳性能影响的研究

为了研究贝尔美对奶牛泌乳性能的影响,选择健康的泌乳奶牛20头,随机分为对照A组和试验B组2组,每组10头;选择患有隐性乳房炎的泌乳奶牛20头,随机分为对照C组与试验D组2组,每组10头。对照组饲喂正常日粮,试验组在正常日粮基础上添加贝尔美预混剂300 mg/kg,分别于0、15、30、45和60 d记录产奶量,并采取乳样,检测乳成分。试验结果显示,在预防试验中,与对照A组相比,试验B组平均每头每天产奶量增加1.90 kg（P〉0.05）,乳脂率、乳蛋白、乳糖、干物质分别提高了3.52%（P〉0.05）、7.21%（P〉0.05）、1.92%（P〉0.05）、6.09%（P〈0.05）。在治疗试验中,与对照C组相比,试验D组的奶牛平均每头每天产奶量增加了2.24 kg（P〈0.05）,乳脂率、乳蛋白、乳糖、干物质分别提高了14.42%（P〈0.05）、10.65%（P〈0.05）、2.02%（P〉0.05）、9.53%（P〈0.05）。综上所述,贝尔美对奶牛隐性乳房炎有一定的防治效果,且能改善乳品质。     

Study of clinical mastitis in British dairy herds with bulk milk somatic cell counts less than 150,000 cells/ml

A 12-month prospective study of clinical mastitis was conducted in 482 British dairy herds with a bulk milk somatic cell count (BMSCC) of less than 150,000 cells/ml. The mean proportion of cows in the herd with clinical mastitis was 23.1 per cent (range 0 to 80), with a mean of 1.50 quarter cases per cow. The mean incidence rate of clinical mastitis was 36.7 quarter cases per 100 cow years (range 0 to 208.2). Twelve per cent of the quarter cases showed systemic signs, including inappetence and severe lethargy. Over 22 per cent of quarter cases occurred in the first seven days of lactation and over 50 per cent occurred in the first 90 days of lactation. Cluster analysis indicated that the main difference between herds with a low and average incidence of mastitis was the proportion of clinical cases occurring in the first seven days of lactation, 14 per cent compared with 44 per cent, respectively. The risk of severe clinical mastitis compared with mild clinical mastitis decreased significantly as the individual cow somatic cell count (SCC) in the month before clinical mastitis was diagnosed increased.     

THE NEW SOUTH WALES MASTITIS CONTROL PROGRAM

SUMMARY A mastitis control program based on teat dipping and dry cow therapy was evaluated in 35 herds over a 3 year period. The incidence of subclinical mastitis as detected by the Rapid Mastitis Test (RMT) fell from 34% to 12% quarters positive, a reduction of 65%. Clinical mastitis was reduced from 37 clinical cases per 100 cows in the first 3 month period to 12 clinical cases per 100 cows in the last 3 month period, a reduction of 68%. Variations in response to the program in the reduction of subclinical and clinical mastitis are discussed and the results compared with similar trials conducted overseas. The Modified Whiteside Test was used on bulk milk samples from the control herds and these results were significantly correlated with the prevalence of subclinical mastitis assessed by RMT individual quarters.     

A benefit to cost analysis of the effect of premilking teat hygiene on somatic cell count and intramammary infections in a commercial dairy herd.

A field trial was conducted to determine the effect of premilking teat disinfection (predipping) on several measures of mastitis in a commercial dairy farm where the predominant organisms isolated from intramammary infections were coagulase negative Staphylococcus spp. Cows were randomly assigned to a treated (predipped with 0.5% iodine germicide plus "good udder preparation") or a control group ("good udder preparation" alone). Sterile composite milk samples were collected at the initiation of the trial and on an approximately bimonthly basis throughout the duration of the trial. There was no difference in the prevalence of isolation of coagulase-negative Staphylococcus spp. from composite milk samples obtained during the 6 herd cultures. The incidence rate for clinical mastitis in the control group was 1.38 cases per 1000 cow days. The incidence rate for clinical mastitis in the treatment group was 1.06 cases per 1000 cow days. The ratio of these 2 was 1.3, suggesting a higher rate in the control group, but the ratio was not statistically significant (P = 0.34). Logistic regression analysis indicated that the effect of treatment group was not significant, although the coefficient suggested that predipping reduced the risk of clinical mastitis. The benefit to cost ratio of 0.37 indicated that the benefit of reduced incidence of clinical cases of mastitis would not have justified the added expense required to predip the herd.     

Milk production increase following treatment of Dutch dairy cattle with thiabendazole

Summary

In a trial involving 542 dairy cattle on 28 farms, 276 were treated once with thiabendazole within two days of calving. The treated group showed an average increase in milk yielded over the non‐return group of 229.8 kg during the subsequent lactation.

In the treated group, total milk fat production was increased over that of the controls by 7.4 kg per cow; milk protein was increased by 6.9 kg per cow. All treatment parameter differences were highly significant at the 1% level of probability.     

Estimation of milk production losses due to sub-clinical mastitis in dairy cattle in Costa Rica

Five dairy farms, situated on the slopes of the volcano Poás in the pre-mountain cloud forest ecological zone, Alajuela and Heredia Provinces, Costa Rica, provided data for estimation of the production losses due to sub-clinical mastitis. Within the same farm, cows with proven sub-clinical mastitis were matched with cows without signs of sub-clinical mastitis, according to breed, lactation number and days in lactation. A total of 529 cows were detected with sub-clinical mastitis, of which only 200 could be paired with control cows free of mastitis; each pair was used only once.

Crude milk production losses per cow with sub-clinical mastitis were estimated at 1.56 kg day⁻¹for daily milk yield. Milk production loss per affected quarter due to sub-clinical mastitis was estimated to be 17.6% on average. The decrease in milk production in heifers with sub-clinical mastitis did not differ significantly from the decrease in production in older cows. No significant difference in milk production loss was detected when the data were stratified on parity or the number of quarters affected.     

金黄色葡萄球菌性奶牛乳房炎多价疫苗的研制和免疫效果评价

为研制用于预防金黄色葡萄球菌性奶牛乳房炎的免疫疫苗,使用4株血清型为外膜多糖336型(336PS)、荚膜多糖5型(CP5)和荚膜多糖8型(CP8)强毒力金黄色葡萄球菌试制出金黄色葡萄球菌多价疫苗,并通过抗体水平监测、攻毒保护试验以及两个牧场的田间试验对免疫效果进行了评价。抗体水平监测显示,首免后30 d即可产生较高的抗体水平,二次免疫后有效抗体水平可持续到产后210 d;人工攻毒保护试验显示,疫苗对金黄色葡萄球菌引起的临床型乳房炎的保护率为89%;田间试验结果表明,该疫苗对奶牛临床型乳房炎的保护率在75.2%～83.3%之间,对隐性乳房炎的保护率在49.9%～52.2%之间,免疫组日产奶量较对照组平均提高1.26 kg以上。上述结果表明,所试制的疫苗可以显著降低泌乳牛金黄色葡萄球菌引起的临床型和隐性乳房炎发病率并提高产奶量。     

Incidence and economics of clinical mastitis in five Holstein herds in the Czech Republic

Data on clinical mastitis (CM) collected between 1996 and 2003 on five Holstein dairy farms in the Czech Republic were analyzed. Lactational incidences of CM, averaged across farms and calculated only from cows with complete lactations, were 0.35, 0.45 and 0.57 for the first, second and third plus subsequent lactations, respectively. The mean numbers of CM cases per cow and lactation were 0.63, 0.94 and 1.22, and the incidence of CM cases per cow-year at risk were 0.68, 1.00 and 1.27 for the first, second and third plus subsequent lactations, respectively. Longitudinal analysis of CM prevalence based on daily records showed the highest proportion of infected cows in the first 10 days of lactation. The within-farm incidence of CM cases per cow per year, averaged over lactations, ranged from 0.53 to 1.56 with a mean value of 0.94 in the whole data set. Direct financial losses from CM per cow per year within farm ranged from 43.63 to 84.84 euros. They included losses from discarded milk, cost for drugs, veterinary service, herdsman's time, cost for an extra milking machine and cost for antibiotic drying of cows. The economic value of CM incidence (change in direct losses per cow per year when increasing CM incidence by one case above the average value) ranged from 58.3 to 80.1 euros per CM case per cow per year with the mean value of 62.6 euros per CM case per cow per year in the total data set. Daily prevalence rate of CM was shown to be the best among various indicators of CM susceptibility, because it accounted for the censored character of the data and for repeated cases of CM within lactations. In order to reduce the incidence of clinical mastitis for dairy cattle in the Czech Republic, we recommend that it should be included as a goal in the breeding program.     

Associations of sole ulcer at claw trimming with reproductive performance, udder health, milk yield, and culling in Swedish dairy cattle

The association between sole ulcer found at routine claw trimming 2–6 months after calving and reproductive, health and productive traits in the same lactation, was investigated in an observational study of 2368 dairy cows in 102 Swedish herds. The data were analysed by mixed multivariable linear-, logistic- and Poisson-regression modelling at the cow level, accounting for clustering within herd. Associations were found between sole ulcer and first-service conception risk in the first study year (OR 0.59), calving interval (2% longer), treatment for anoestrus (OR 1.61), and 305-day milk yield (479 kg ECM higher). No associations could be shown between sole ulcer and first-service conception risk in the second study year, the number of services per conception, clinical mastitis, high milk somatic-cell counts or culling.     

复合草颗粒生产及饲喂奶牛试验

通过刈割-干燥-粉碎-配制-制粒程序将紫花苜蓿(Medicago sativa)鲜草加工成理想的高附加值商品--复合草颗粒,同时采用随机编号、分组试验法,替代2.5、2.0 kg精饲料饲喂奶牛,测定替代量与产奶量、草料消耗成本之间的关系.结果表明,复合草颗粒是一种体积小,便于运输、贮藏,使用方便,适口性好,营养价值高的...